Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas.
An integrated clinical program and crowdsourcing strategy for genomic sequencing and Mendelian disease gene discovery.
novoCaller: a Bayesian network approach for de novo variant calling from pedigree and population sequence data.